Department of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan Province, China.
Ann Thorac Surg. 2011 Aug;92(2):710-3. doi: 10.1016/j.athoracsur.2011.03.004.
This report details our preliminary results for sheath-assisted tracheal intubation (SATI) for patients with acute dyspnea caused by severe stenoses in the larynx or trachea.
Of 289 patients with acute dyspnea who required tracheal intubation in the emergency department of our hospital, 21 who experienced intubation difficulty or failure were entered into this study. Data on technical success, clinical outcome, and complications related to SATI were collected and analyzed retrospectively.
Sheath-assisted tracheal intubation was successful in all patients. Clinical success was observed in all patients 1 to 7 days after the procedure. Tracheal stents or incisions, or both, were performed 1 to 3 days after SATI for all patients, once their general physical condition had improved. During follow-up, acute dyspnea had resolved in all patients. At the time of this report, 18 patients were well, with no dyspnea, but 3 patients had died, 2 of lung cancer and 1 of carcinoma of the larynx.
Shealth-assisted tracheal intubation is a safe and feasible procedure, and may serve as an additional treatment option for patients with acute dyspnea caused by severe stenoses of the larynx or trachea.
本报告详细介绍了我们在喉或气管严重狭窄导致急性呼吸困难的患者中行鞘管辅助气管插管（SATI）的初步结果。
在我院急诊科收治的 289 例急性呼吸困难需行气管插管的患者中，21 例患者插管困难或失败，被纳入本研究。回顾性收集并分析与 SATI 相关的技术成功率、临床结局和并发症的数据。
所有患者均成功实施鞘管辅助气管插管。所有患者在术后 1-7 天临床均成功。所有患者在 SATI 后 1-3 天行气管支架或切开术，待一般身体状况改善后进行。在随访期间，所有患者的急性呼吸困难均得到缓解。截至本报告时，18 例患者情况良好，无呼吸困难，但 3 例患者死亡，2 例死于肺癌，1 例死于喉癌。
鞘管辅助气管插管是一种安全可行的方法，可能为喉或气管严重狭窄导致的急性呼吸困难患者提供额外的治疗选择。
